You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Litigation Details for Finjan, Inc. v. Check Point Software Technologies, Inc. (N.D. Cal. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Finjan, Inc. v. Check Point Software Technologies, Inc. (N.D. Cal. 2018)

Docket ⤷  Try a Trial Date Filed 2018-05-03
Court District Court, N.D. California Date Terminated
Cause 15:1126 Patent Infringement Assigned To William Horsley Orrick III
Jury Demand Both Referred To
Parties CHECK POINT SOFTWARE TECHNOLOGIES, INC.; CHECK POINT SOFTWARE TECHNOLOGIES, LTD.; ESET, LLC; ESET, SPOL. S.R.O.; FINJAN, INC.; SOPHOS INC.
Patents 10,010,612; 10,010,777; 10,012,213; 10,016,415; 10,213,415; 10,415,014; 6,268,010; 7,001,773; 7,014,990; 7,777,028; 8,008,003; 8,268,008; 8,629,185; 8,685,957; 8,962,685; 9,266,949; 9,266,957; 9,415,004; 9,415,007; 9,415,008; 9,415,009; 9,415,016; 9,415,025; 9,962,373; 9,962,466
Attorneys Alyssa M. Caridis; Amy Kathleen VanZant; Austin W Manes; Clement S. Roberts; Evan David Brewer; Frances Cheever; James R. Hannah; Jason Yu; Justin Edwin Gray; Kathryn Riley Grasso; Kristopher Benjamin Kastens; Laura Michelle Chavkin; Linjun Xu; Lisa Kobialka; Margaret Anne Abernathy; Matthew Herman Poppe; Paul J. Andre; Scott Adam Penner; Vickie L. Feeman; Yuridia Caire
Firms DLA Piper US; Eversheds Sutherland (US) LLP; Kramer Levin Naftalis & Frankel LLP; Orrick Herrington & Sutcliffe LLP; Orrick Herrington and Sutcliffe LLP; Orrick, Herrington & Sutcliffe, LLP; Rimon P.C.; Yuridia Caire
Link to Docket External link to docket
Small Molecule Drugs cited in Finjan, Inc. v. Check Point Software Technologies, Inc.
Biologic Drugs cited in Finjan, Inc. v. Check Point Software Technologies, Inc.

Details for Finjan, Inc. v. Check Point Software Technologies, Inc. (N.D. Cal. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-03-28 264 Opposition/Response to Motion 8 Federal Circuit Model Order Limiting Excess Patent Claims and Prior Art], the Patent Local …Holder, 13 640 F.3d 962 (9th Cir. 2011) (per curiam) ....................…v. Holder, 640 F.3d 23 962, 966 (9th Cir. 2011) (per curiam)). If the moving… 12 Perez v. Holder, 640 F.3d 962 (9th Cir. 2011). Finjan does not even acknowledge…; Station Emps., 20 685 F.2d 1065 (9th Cir.1982), 466 U.S. 435 (1984) ... External link to document
2020-04-21 267 Order on Motion for Certificate of Appealability 8 under specifications that largely follow the provisions of this District’s Patent Local Rules…only Patent Local Rule 3-1, but also the criteria specified 8 in…for difference.” Couch v. Telescope Inc., 611 F.3d 629, 633 (9th 16 …which amounted to 5,135 charts, totaling to over 185,000 pages. See Order Granting in Part … 13 more than 185,000 pages. SAIC Order at 7. Check Point moved to External link to document
2020-05-28 268 Stipulation and Proposed Order Facsimile: (213) 612-2499 15 … 3 May 2018 3:18-cv-02621 Patent Both District Court, N.D. California… Facsimile: (650) 614 7401 FINJAN, INC. 10 … a stipulated 8 dismissal with prejudice. 9 10 IT IS SO STIPULATED. 11 12 … CHECK POINT SOFTWARE 10 External link to document
2020-05-29 270 Patent/Trademark Report Technologies, Inc. 3 May 2018 3:18-cv-02621 Patent Both District Court…HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. TRADEMARK 1 2 3 4 5 In…HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. TRADEMARK 1 2 3 4 5 In… Case 3:18-cv-02621-WHO Document 270 Filed 05/29/20 Page 1 of 1 AO 120 (Rev. 08/10) (CAND version… Trademarks or ☒ Patents. (☐ the patent action involves 35 U.S.C. § 292.): External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.